PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNK.L Regulatory News (DNK)

  • There is currently no data for DNK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AFC investment update

26 Oct 2020 07:00

RNS Number : 1302D
Danakali Limited
26 October 2020
 

Announcement

Monday, 26 October 2020

AFC investment update

Danakali Limited (ASX: DNK, LSE: DNK, "Danakali" or the "Company"), provides today an update on Tranche 2 of Africa Finance Corporation's ("AFC") equity funding ("Tranche 2"), which was first announced on 3 December 2019.

 

Danakali and AFC have been working in good faith to satisfy the conditions precedent for AFC's Tranche 2 of US$28.5m. The Board of Danakali now considers it unlikely that all such conditions precedent will be satisfied prior to the deadline of 21 November 2020 (refer announcement 1 June 2020). Therefore, Tranche 2 will not complete in accordance with the terms of the subscription agreement.

 

As an international financial institution with a mandate to support infrastructure and industrial development in Africa, AFC's support of the development of the Colluli Project remains firm. As Danakali's largest shareholder and one of the two mandated lead arrangers and lender under the Colluli Project's US$200m Debt Financing, AFC is in discussion with Danakali with a view to finding a funding structure suitable to both parties that will ensure the commencement of construction of the project as soon as possible.

 

Samaila D Zubairu, President and CEO of AFC, commented: "AFC's mandate is to develop Africa and ensure that more of the value of the continent's resources benefit the continent's people through the creation of jobs and opportunities along with improving living standards. AFC are fully committed to seeing Colluli developed as quickly and safely as possible and look forward to working with the key stakeholders, ENAMCO, Afreximbank and Danakali on this important objective and ensure the project is fully funded as soon as possible so production commences in 2022."

 

 

Announcement authorised for release by the Board of Danakali.

 

For more information, please contact:

 

Danakali

Niels Wage

Chief Executive Officer / +61 8 6189 8635

Mark Riseley

Corporate Development Manager / +61 8 6189 8635

Corporate Broker - Canaccord

UK IR/PR - Instinctif Partners

James Asensio/Angelos Vlatakis

+44 (0)20 7523 4680

Mark Garraway / Dinara Shikhametova / Sarah Hourahane

danakali@instinctif.com / +44 (0)207 457 2020

 

 

 

 

Visit the Company's website: www.danakali.com

Follow Danakali on LinkedIn: www.linkedin.com/company/danakali-limited

Subscribe to Danakali on YouTube: www.youtube.com/channel/UChGKN4-M4lOvPKxs9b-IJvw

 

 

 

 

 

About Danakali

 

Danakali Limited (ASX: DNK, LSE: DNK) (Danakali, or the Company) is an ASX- and LSE-listed potash company focused on the development of the Colluli Sulphate of Potash Project (Colluli or the Project). The Project is 100% owned by the Colluli Mining Share Company (CMSC), a 50:50 joint venture between Danakali and the Eritrean National Mining Corporation (ENAMCO).

 

The Project is located in the Danakil Depression region of Eritrea, East Africa, and is ~75km from the Red Sea coast, making it one of the most accessible potash deposits globally. Mineralisation within the Colluli resource commences at just 16m, making it the world's shallowest known potash deposit. The resource is amenable to open cut mining, which allows higher overall resource recovery to be achieved, is generally safer than underground mining, and is highly advantageous for modular growth.

 

The Company has completed a Front End Engineering Design (FEED) for the production of potassium sulphate, otherwise known as Sulphate of Potash or SOP. SOP is a chloride free, specialty fertiliser which carries a substantial price premium relative to the more common potash type; potassium chloride (or MOP). Economic resources for production of SOP are geologically scarce. The unique composition of the Colluli resource favours low energy input, high potassium yield conversion to SOP using commercially proven technology. One of the key advantages of the resource is that the salts are present in solid form (in contrast with production of SOP from brines) which reduces infrastructure costs and substantially reduces the time required to achieve full production capacity.

 

The resource is favourably positioned to supply the world's fastest growing markets. A binding take-or-pay offtake agreement has been confirmed with EuroChem Trading GmbH (EuroChem) for up to 100% (minimum 87%) of Colluli Module I SOP production.

 

Development Finance Institutions, Africa Finance Corporation (AFC) and African Export-Import Bank (Afreximbank), have obtained formal credit approval to provide CMSC with US$200M in senior debt finance. The credit documentation was executed in December 2019, allowing drawdown of CMSC senior debt on satisfaction of customary conditions precedent. This represents the majority of funding required for the development and construction of the Colluli. AFC has invested US$21.5M (A$31.8M) in equity which allowed commencement of the development.

 

Project execution has commenced and SOP production is expected during 2022. The Company's vision is to bring Colluli into production using the principles of risk management, resource utilisation and modularity, using the starting module (Module I) as a growth platform to develop the resource to its full potential.

 

 

Disclaimer

 

The information in this document is published to inform you about Danakali and its activities. Danakali has endeavoured to ensure that the information enclosed is accurate at the time of release, and that it accurately reflects the Company's intentions. To the extent permitted by law, the Company accepts no responsibility or liability for any losses or damages of any kind arising out of the use of any information contained in this document. Recipients should make their own enquiries in relation to any investment decisions.

 

 

No representation or warranty, express or implied, is or will be made by or on behalf of the Company, and no responsibility or liability is or will be accepted by the Company or its affiliates, as to the accuracy, completeness or verification of the information set out in this announcement, and nothing contained in this announcement is, or shall be relied upon as, a promise or representation in this respect, whether as to the past or the future. The Company and each of its affiliates accordingly disclaims, to the fullest extent permitted by law, all and any liability whether arising in tort, contract or otherwise which it might otherwise have in respect of this announcement or any such statement.

 

The distribution of this announcement outside the United Kingdom may be restricted by law and therefore any persons outside the United Kingdom into whose possession this announcement comes should inform themselves about and observe any such restrictions in connection with the distribution of this announcement. Any failure to comply with such restrictions may constitute a violation of the securities laws of any jurisdiction outside the United Kingdom.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDPPGCGUUPUPWA
Date   Source Headline
18th Sep 20197:27 amRNSProactive One2One Investor Forum presentation
13th Sep 20197:00 amRNSHY 2019 Financial Report
3rd Sep 20197:00 amRNSTotal Voting Rights and Capital
12th Aug 20197:00 amRNSAppendix 3B
12th Aug 20197:00 amRNSIssue of equity and total voting rights
12th Aug 20197:00 amRNSIssue of shares - s708A Notice
8th Aug 20197:00 amRNSCredit approval for Colluli power plant
5th Aug 20197:00 amRNSCredit approval for US$200M senior debt facility
1st Aug 20197:00 amRNSTotal Voting Rights
29th Jul 20197:00 amRNSQuarterly Report and Appendix 5B
15th Jul 20197:00 amRNSProactive Investors presentation
1st Jul 20197:00 amRNSTotal Voting Rights and Capital
28th Jun 20197:00 amRNSReport on Payments to Governments
14th Jun 20199:30 amRNSNotification of PDMR and PCA Transactions
14th Jun 20199:30 amRNSAppendix 3Y - A Liebenberg
14th Jun 20199:30 amRNSAppendix 3B
14th Jun 20199:30 amRNSAppendix 3Y - S Cornelius
14th Jun 20199:30 amRNSIssue of Securities
3rd Jun 20197:00 amRNSTotal Voting Rights
29th May 20197:00 amRNSReplacement Constitution
28th May 20197:00 amRNSResults of Annual General Meeting
10th May 20198:50 amRNSTR-1:Notification of Major Holdings
1st May 20197:00 amRNSTotal voting rights and capital
30th Apr 20197:00 amRNSQuarterly Report and Appendix 5B
24th Apr 20197:05 amRNSNotice of AGM
24th Apr 20197:00 amRNSNotification of PDMR transaction
24th Apr 20197:00 amRNSIssue of Options
24th Apr 20197:00 amRNSAppendix 3B
16th Apr 20197:09 amRNSRelease of 2018 Annual Report
2nd Apr 20197:00 amRNSTotal Voting Rights
26th Mar 20197:00 amRNSNotification of PCA transaction
26th Mar 20197:00 amRNSAppendix 3B
26th Mar 20197:00 amRNSIssue of options
25th Mar 20197:00 amRNSAppointment of new CEO
20th Mar 20197:00 amRNSDanakali 2018 Financial Report
7th Mar 20197:00 amRNSProactive Investors 121 Natural Resources Forum
4th Mar 20197:00 amRNSNotification of PCA transaction
4th Mar 20197:00 amRNSAppendix 3B
4th Mar 20197:00 amRNSIssue of Options
1st Mar 20197:02 amRNSTotal voting rights and capital
1st Mar 20197:00 amRNSChange of address
1st Feb 20197:00 amRNSTotal Voting Rights
31st Jan 20197:00 amRNSQuarterly Report and Appendix 5B
30th Jan 20197:00 amRNSUNDP report outlines potential for Colluli
3rd Jan 20197:00 amRNSUpdate on Issue of Equity and Total Voting Rights
21st Dec 20187:00 amRNSAppendix 3B
21st Dec 20187:00 amRNSIssue of Shares - s708A Notice
6th Dec 20187:00 amRNSUS$200m debt finance mandate executed
3rd Dec 20187:00 amRNSTotal Voting Rights
15th Nov 20187:00 amRNSResponse to Lifting of UN Sanctions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.